Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Large Growth in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 17,500 shares, an increase of 21.5% from the November 15th total of 14,400 shares. Based on an average daily volume of 20,900 shares, the short-interest ratio is presently 0.8 days.

Reviva Pharmaceuticals Price Performance

Shares of NASDAQ RVPHW traded down $0.04 during trading on Friday, hitting $0.31. 18,848 shares of the company were exchanged, compared to its average volume of 18,631. Reviva Pharmaceuticals has a 1 year low of $0.07 and a 1 year high of $1.62. The firm’s fifty day moving average price is $0.17 and its 200 day moving average price is $0.18.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.